Skip to content
DataLookout
Menu

NCT07936669

Vaginal Flora Modulation With Lactobacillus and Estriol in Threatened Preterm Labor

StatusCompleted
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Change in Vaginal pH From Baseline to Day 14
Timeframe: Baseline (Day 0) to Day 14

Arms and interventions

6-Day Gynoflor GroupActive comparator

Participants receive one Gynoflor® vaginal tablet once daily for 6 consecutive days. Each vaginal tablet contains Lactobacillus acidophilus KS400 (100 × 10⁶ CFU) and estriol 0.03 mg.

12-Day Gynoflor GroupExperimental

Participants receive one Gynoflor® vaginal tablet once daily for 12 consecutive days. Each vaginal tablet contains Lactobacillus acidophilus KS400 (100 × 10⁶ CFU) and estriol 0.03 mg.

Drugs: Lactobacillus acidophilus and estriol

Sites

1 site in 1 country

  • Queen Savang Vadhana Memorial HospitalChon Buri, Thailand